Thirdly, oesophageal SCC patients with both HLA-A24-and HER-2-positive tumours (1+/2+/3+) accounted for 26% of these cases, and both HLA-A2- and HER-2-positive tumours accounted for 18% of them. This evidence concerns the gene ERBB2 and neoplasm.